MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Closed-loop gait improvement in Parkinson’s Disease

    P. Kirsch, M. Helbig, S. Baudrexel, C. Kell (Frankfurt am Main, Germany)

    Objective: The aim of this study was to measure gait parameters of patients with Parkinson’s Disease (PD) in everyday life situations and improve hypokinetic gait…
  • 2023 International Congress

    Risk and protective factors in Parkinson’s disease: a simultaneous and prospective study with linear and machine learning models

    MI. de Bartolo, A. Gialluisi, S. Costanzo, D. Belvisi, S. Falciglia, M. Ricci, A. Di Castelnuovo, T. Panzera, MB. Donati, G. Fabbrini, G. de Gaetano, A. Berardelli, L. Iacoviello (Pozzilli, Italy)

    Objective: To identify which risk/protective factors influenced most incident Parkinson's disease (PD) risk in a population of almost 24,000 Italian citizens, using both classical statistical…
  • 2023 International Congress

    Taking the driver’s seat on Parkinson’s care

    J. Benalcazar Silva (Melbourne, Australia)

    Objective: To provide insight into the unique service and support offered by the multidisciplinary health team to address the challenges and dilemmas faced by people…
  • 2023 International Congress

    Effect of intensive Game-based neurorehabilitation (GBNR) on gait, balance and quality of life (QOL) in Parkinson’s patients: A prospective randomized control study

    R. Savaj, P. Vengurlekar, C. Sankhla, S. Patel (Mumbai, India)

    Objective: To assess changes in the gait, balance and QOL in PD patients subjected to intensive GBNR in comparison with conventional Neurorehabilitation (NR) therapy using…
  • 2023 International Congress

    Effect of Best Practice Advisory on the administration of contraindicated medications to hospitalized patients with Parkinson’s disease and related disorders

    N. Chunga, K. Amodeo, M. Braun, B. Valdovinos, I. Richard (Rochester, USA)

    Objective: To determine if a best practice advisory (BPA) reduced the orders and administration of contraindicated dopamine blocking agents (DBA) to hospitalized patients with Parkinson’s…
  • 2023 International Congress

    Patients activation in people with Parkinson disease and its relation to personal factors

    B. Naamneh Abuelhija, M. Kafri, M. Kestenbaum, S. Giveon, G. Yogev-Seligmann (Haifa, Israel)

    Objective: To identify individual factors associated with patient activation among people with Parkinson’s disease (PD). Background: The concept of patient activation captures subjective aspects of…
  • 2023 International Congress

    A vicious cycle of karyopherin abnormalities in synucleinopathies

    D. Sharipov, E. Bereczki, R. Killick, T. Hortobagyi, C. Troakes, D. Aarsland, F. Hirth (London, United Kingdom)

    Objective: This study aims to investigate the role of karyopherin abnormalities in the onset and progression of synucleinopathies. Background: Despite differences in clinical manifestations, Parkinson’s…
  • 2023 International Congress

    Electrophysiological correlates of the increase in rigidity with the Froment maneuver in Parkinson’s patients

    M. Yücel, T. Odorfer, D. Zeller, J. Volkmann (Würzburg, Germany)

    Objective: To investigate the physiological basis underlying the increase of rigidity during co-innervation (Froment maneuver) in Parkinson´s disease (PD) patients and to probe whether this…
  • 2023 International Congress

    Effects of cerebellar theta burst stimulation on working memory in Parkinson’s disease

    N. Raies, J-F. Nankoo, T. Grippe, R. Chen (Toronto, Canada)

    Objective: This study aims to investigate the effects of cerebellar theta burst stimulation (TBS) on working memory (WM) performance in patients with Parkinson’s disease (PD)…
  • 2023 International Congress

    Placebo response in Parkinson’s disease (PD) is predicted by expression levels of a specific brain network

    J. Barbero, C. Tang, A. Vo, Y. Ma, S. Peng, B. Brakedal, C. Dölle, N. Brekke, C. Tzoulis, D. Eidelberg (Manhasset, USA)

    Objective: To determine whether baseline expression levels for the previously validated sham surgery-related metabolic pattern (SSRP) can be used to predict the magnitude of the…
  • « Previous Page
  • 1
  • …
  • 120
  • 121
  • 122
  • 123
  • 124
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley